| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $273.9M | +29.5% |
| Cost of Revenue | $223.8M | +27.6% |
| Gross Profit | $50.0M | +51.9% |
| R&D Expense | $3.0M | -10.3% |
| SG&A Expense | $40.4M | +26.5% |
| Operating Income | $4.4M | +199.0% |
| Interest Expense | $4.6M | +122.5% |
| Pre-tax Income | -$2.2M | +34.9% |
| Income Tax | $2.1M | +73.7% |
| Net Income | -$4.9M | -7.2% |
| EPS (Basic) | -$0.21 | +8.7% |
| EPS (Diluted) | -$0.21 | +8.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.0M | -62.7% |
| Accounts Receivable | $43.9M | +43.7% |
| Inventory | $69.8M | +7.4% |
| Current Assets | $127.5M | +4.9% |
| Total Assets | $236.6M | +31.6% |
| Current Liabilities | $86.5M | +5.6% |
| Long-term Debt | $86.4M | +109.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | -168.0% |
| Capital Expenditures | $16.1M | +1707.8% |
| Investing Cash Flow | -$52.6M | -4528.6% |
| Financing Cash Flow | $45.9M | — |
| Free Cash Flow | -$21.2M | -422.2% |
| Total Liabilities |
| $168.6M |
| +44.2% |
| Stockholders' Equity | $58.4M | -7.0% |